The costs of triple-drug anti-HIV therapy or adults in the Americas [6]

JAMA

Volumn 279, Issue 16, 1998, Pages 1263-1264

  Montaner, J S G ^a   Hogg, R S ^a   Weber, A E ^a   Anis, A H ^a   O'Shaughnessy, M V ^a   Schecter, M T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

COMBINATION CHEMOTHERAPY; COST BENEFIT ANALYSIS; DRUG COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL;

EID: 0032557168     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.16.1259     Document Type: Letter

References (5)